Serum and Cerebrospinal-Fluid Transaminase Concentrations in Various Neurologic Disorders
- 8 August 1957
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 257 (6) , 273-276
- https://doi.org/10.1056/nejm195708082570606
Abstract
THE enzyme glutamic oxalacetic transaminase (GOT) is widely distributed in animal tissues but appears to be most concentrated in the myocardium, liver, skeletal muscle, brain and kidney.1 2 3 It has been repeatedly demonstrated that a rise in the serum level of GOT follows acute damage to the myocardium, liver and skeletal muscle. Relatively little work has been done on the effect of neurologic disorders on GOT levels. Wakim and Fleisher4 have demonstrated that experimental cerebral infarction in dogs leads to a marked increase in the activity of GOT in cerebrospinal fluid roughly proportional to the extent and severity of the infarct. . . .Keywords
This publication has 5 references indexed in Scilit:
- Cerebrospinal-Fluid Transaminase Concentrations in Clinical Cerebral InfarctionsNew England Journal of Medicine, 1957
- The Significance of the Serum Glutamic Oxalacetic Transaminase Activity Following Acute Myocardial InfarctionCirculation, 1955
- THE SCOPE OF THE TRANSAMINATION REACTION IN ANIMAL TISSUESJournal of Biological Chemistry, 1950
- PYRUVIC ACIDJournal of Biological Chemistry, 1943
- RATE OF TRANSAMINATION IN NORMAL TISSUESPublished by Elsevier ,1941